The Project Grant award R03AG087423 from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to uncover mechanisms by which visual system dysfunction contributes to the onset and progression of Alzheimer's disease (AD). The $309,960 project, awarded from May 2024 to April 2026, aims to determine how the presence of pathological amyloid and tau proteins in the eye and primary visual cortex affects the structure and function of the primary visual pathway to the brain. This work will provide preliminary data to identify potential intervention targets that can protect both visual function and overall disease progression in AD. Northeast Ohio Medical University (Neomed) is the primary awardee for this grant. Neomed has also received numerous other federal research grants from NIH institutes and contracts from the Department of the Navy to provide specialized medical education services.
Generated 2/25/25, 4:27 AM